Who is sponsoring NCT03487393?

NCT03487393 is sponsored by Nervive, Inc..

What drugs are being tested in NCT03487393?

Interventions in NCT03487393: magnetic facial nerve stimulation.

What condition does NCT03487393 study?

NCT03487393 studies Normal Subject / Healthy Volunteers.

Is NCT03487393 still recruiting?

NCT03487393 is currently completed. Last updated 4 April 2018.

Last reviewed 2018-04-04 · How we verify

NCT03487393

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

VitalFlow Healthy Volunteer Study

Completed NA Last updated 4 April 2018

What this trial tests

NA trial testing magnetic facial nerve stimulation in Normal Subject / Healthy Volunteers in 37 participants. Completed in 8 January 2016.

Timeline

19 October 2015

Primary endpoint
15 December 2015

8 January 2016

Quick facts

Lead sponsor	Nervive, Inc.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	37
Start date	19 October 2015
Primary completion	15 December 2015
Estimated completion	8 January 2016
Sites	1 location across Mexico

Drugs / interventions tested

magnetic facial nerve stimulation

Conditions studied

Normal Subject / Healthy Volunteers — all drugs for Normal Subject / Healthy Volunteers →

Sponsor

Nervive, Inc.

Who can join

Adults 20 to 40, any sex, with Normal Subject / Healthy Volunteers. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Find the stimulation threshold of the facial nerve (ganglion Geniculate) associated with tolerability and safety in subjects Healthy humans.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Nervive, Inc. trials

Trials by the same sponsor.

NCT04801225 — Early Feasibility Study of the Nervive VitalFlow Stimulation for Acute Ischemic Stroke Patients · NA · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03487393 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Nervive, Inc.
Last refreshed: 4 April 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03487393.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing